Ubretid
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-119577-1MG | 1 mg | 241,00 | Add | |
| HY-119577-5MG | 5 mg | 673,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Ubretid is a potent inhibitor of plasma cholinesterase. Ubretid therefore delays the hydrolysis of suxamethonium and prolongs its action, similar to the effects shown by other anticholinesterase agents, such as pyridostigmine and donepezil. Ubretid has the potential for the research of urinary retention prolongs the effect of suxamethonium. Ubretid is commonly prescribed for the research of myasthenia gravis and for difficulty in emptying the bladder[1].
| Category | Protein |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Neurological Disease, Neuronal Signaling |
| Format | Solubility: DMSO : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99% |
| Molecular Formula | C22H32Br2N4O4 |
| Molecular Weight | 576.32 |
| CAS-Number | 15876-67-2 |
| Storage Conditions | 4°C (Powder, sealed storage, away from moisture) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
